BrightGene Bio-Medical Technology688166 
$3.384.04%24h
4.04%24h
Global rank6366
Market cap$1.43B
Change 7d3.19%
YTD Performance-29.70%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of BrightGene Bio-Medical Technology (688166)
As of November 2024, BrightGene Bio-Medical Technology has a market cap of $1.43B. This makes BrightGene Bio-Medical Technology the world's 6366th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of BrightGene Bio-Medical Technology from 2019 to 2024
-
Value:-
Market cap history of BrightGene Bio-Medical Technology from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.47B | -29.54% |
| 2023 | $2.09B | 55.07% |
| 2022 | $1.35B | -38.52% |
| 2021 | $2.19B | -19.85% |
| 2020 | $2.73B | 44.16% |
| 2019 | $1.90B | - |
688166 Market Cap Today is $1.43B 4.04% - 23 Nov 2024
View largest stocks by market cap 
